A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

NCT04664504 ·Status: RECRUITING ·Phase: PHASE2

Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute

NCT05607186 ·Status: COMPLETED

Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer

NCT01271192 ·Status: UNKNOWN ·Phase: NA

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Neoadjuvant Radiotherapy Before Surgery for Rectal Cancer, Surgical and Oncological Outcome Analysis, Retrospective Case Control Study in a Single Institute.

NCT06713824 ·Status: ACTIVE_NOT_RECRUITING

Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

NCT07337811 ·Status: RECRUITING ·Phase: NA

Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma

NCT05563922 ·Status: RECRUITING ·Phase: PHASE2

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

NCT02860234 ·Status: COMPLETED

Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

NCT00682786 ·Status: COMPLETED ·Phase: PHASE2

Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission

NCT05964530 ·Status: RECRUITING ·Phase: NA

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

NCT06304987 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody

NCT06014944 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

NCT05575635 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study on the Applicability of CCR Criteria in Rectal Cancer

NCT06794099 ·Status: COMPLETED

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

NCT04543695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Observational Study on the Patients With Rectal Cancer

NCT02312284 ·Status: COMPLETED

Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

NCT04227886 ·Status: UNKNOWN

Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer

NCT04287400 ·Status: RECRUITING

Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors

NCT06566222 ·Status: NOT_YET_RECRUITING

Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis

NCT03149978 ·Status: UNKNOWN

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors

NCT03177382 ·Status: UNKNOWN ·Phase: PHASE3

Total Neoadjuvant Therapy in Rectal Cancer

NCT06162650 ·Status: RECRUITING ·Phase: PHASE2

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

NCT05969938 ·Status: UNKNOWN

Exploring the Predictive Effect of Intestinal and Oral Microbiota on the Efficacy of Neoadjuvant Radiotherapy and Chemotherapy for Locally Advanced Rectal Cancer Based on Machine Learning

NCT07346729 ·Status: COMPLETED

Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer

NCT06879197 ·Status: COMPLETED